Showing results (1511-1520 of 1,623) with videos related to

Sort By:
Pageof 163
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2014
Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemiaBoglarka Gyurkocza, Jonathan Gutman, Eneida R Nemecek, et al.
British Journal of Clinical Pharmacology|November 20, 2024
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trialsKrzysztof Kalwak, Ajay Vora, Peter Bader, et al.
Journal of the Canadian Association of Gastroenterology|December 5, 2022
Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort StudyCynthia H Seow, Stephanie Coward, Karen I Kroeker, et al.
Kidney International Reports|March 20, 2023
Australian Workshops on Patients' Perspectives on Hemodialysis and Incremental StartKatharine Hegerty, Allison Jaure, Nicole Scholes-Robertson, et al.
Gastroenterology|December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's DiseaseJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
American Journal of Physiology. Renal Physiology|August 30, 2013
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin miceTimothy Sullivan, Zhenhua Miao, Daniel J Dairaghi, et al.
Protein Science : a Publication of the Protein Society|September 13, 2025
Genetic code expansion and enzymatic modifications as accessible methods for studying site-specific post-translational modifications of alpha-synuclein and tauIbrahim G Saleh, Marie Shimogawa, Jennifer Ramirez, et al.
BMJ Open|November 6, 2020
Patient needs and priorities for patient navigator programmes in chronic kidney disease: a workshop reportChandana Guha, P Lopez-Vargas, Angela Ju, et al.
Bone Marrow Transplantation|December 14, 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningJ Casper, J Holowiecki, R Trenschel, et al.
Pageof 163